IL9 and neoplasm: In subsequent experiments, we performed studies in the syngenic LL/2 model and analyzed the direct anti-tumoral function of IL-9 on the tumor cell line LL/2 by using Ki67 and AnnexinV/PI as proliferation and apoptosis markers, respectively (Figures 6A, B).